Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)

A Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Etoricoxib 60 mg and Diclofenac Sodium 150 mg in Patient With Osteoarthritis of the Knee or Hip

To compare the safety and tolerability of etoricoxib and diclofenac sodium in the treatment of osteoarthritis of the knee or hip during a six week period.

Inclusion Criteria:

• Patient is at least 40 years old and diagnosed with osteoarthritis of the knee or hip
• Has a history of treatment with NSAIDs with positive therapeutic benefit
• Agree to limit alcohol intake to less than 7 drinks per week and avoid unusual strenuous activity
• Females who are able to have children must have negative urine pregnancy tests

Exclusion Criteria:

• Has rheumatoid arthritis, lupus, Paget's disease affecting the study joint, or Wilson's disease
• History of acute ligament or meniscus damage to the study joint (knee or hip) within the past 2 years or arthroscopic surgery on the affected study joint with the past 6 months
• Requires joint replacement